Botanix presents at European Dermatology Conference
· Botanix will be presenting at the 27th EADV Congress in Paris, France
· Botanix will provide an update on its Phase 2 products and other pipeline products
· Botanix will have the opportunity to engage with market leading global pharmaceuticals organisations and researchers
Philadelphia PA and Sydney Australia, 13th September 2018 -- Medical dermatology company Botanix Pharmaceuticals Limited (ASX: BOT, “Botanix” or the “Company”) is pleased to release an updated company presentation for the 27th Congress of the European Academy of Dermatology and Venerology (EADV Congress), held in Paris, France.
Have you seen our earlier videos?
P: +1 215 767 4184
P: +61 3 8582 4800
The Capital Network
P: +61 419 815 386